Literature DB >> 1966813

Cooperation between tumor necrosis factor (TNF) and platelet-activating factor (PAF) in the inflammatory response.

C Maestre1, P Zarco, C Gómez-Guerrero, E González, G Herrero-Beaumont, M Braquet, J Egido.   

Abstract

In this paper we have examined the cooperation between TNF and PAF in the generation of superoxide anion (O2-) in vitro by polymorphonuclear cells (PMNs), as well as their ability to induce joint inflammation when injected into the knee of healthy rabbits. TNF and PAF directly stimulated the generation of a small amount of O2- by PMNs. TNF pretreatment of PMNs induced a certain synergy in the O2- production, when these cells were later stimulated with PAF. When PAF receptor antagonists were added, the O2- release was inhibited. The injection of either TNF or PAF into the knee joint of normal rabbits induced a dose-dependent accumulation of leukocytes in the synovial cavity 24 h after administration. When TNF was administered 1 h before PAF, a synergistic response in the accumulation of leukocytes in the joint fluid was noted. The administration of BN 52726 by the intraperitoneal route markedly inhibited the cell accumulation induced by TNF and PAF. Histological signs of inflammation were noted in the synovial lining of joints injected with TNF and PAF. These results suggest that TNF can amplify the inflammatory response induced by PAF. PAF antagonists can inhibit this effect and thus may be of therapeutic value in different pathological situations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1966813

Source DB:  PubMed          Journal:  J Lipid Mediat        ISSN: 0921-8319


  7 in total

Review 1.  PAF. A review of its effects, antagonists and possible future clinical implications (Part II).

Authors:  M Koltai; D Hosford; P Guinot; A Esanu; P Braquet
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

2.  Recombinant tumour necrosis factor-alpha and platelet-activating factor synergistically increase intercellular adhesion molecule-1 and E-selectin-dependent neutrophil adherence to endothelium in vitro.

Authors:  A Sterner-Kock; R K Braun; M D Schrenzel; D M Hyde
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

Review 3.  Significance of lipid mediators in corneal injury and repair.

Authors:  Sachidananda Kenchegowda; Haydee E P Bazan
Journal:  J Lipid Res       Date:  2009-11-03       Impact factor: 5.922

4.  Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders.

Authors:  Dawn Eggert; Prasanta K Dash; Nawal Serradji; Chang-Zhi Dong; Pascal Clayette; Francoise Heymans; Huanyu Dou; Santhi Gorantla; Harris A Gelbard; Larisa Poluektova; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2009-06-21       Impact factor: 3.478

Review 5.  The role of platelet-activating factor (PAF) in experimental glomerular injury.

Authors:  A Ortiz; M Gomez-Chiarri; J L Lerma; E Gonzalez; J Egido
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

6.  Effects of esculentoside A on turnour necrosis factor production by mice peritoneal macrophages.

Authors:  F Jun; Z Q Yue; W H Bin; J D Wen; Y Y Hua
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

7.  Inhibitory effect of esculentoside A on tumour necrosis factor alpha production by human monocytes.

Authors:  H B Wang; J Fang; Q Y Zheng
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.